Discussion Sessions - Topics for 8:00 a.m. Sessions

To access the PDF version of the articles listed below please click here and login.


1. Cassel EJ. The nature of suffering and the goals of medicine. NEJM. 1982, 306:639-45.

2. Steinhauser KE, et al. In search of a good death: Observations of patients, families, and providers. Ann Intern Med. 2000, 132(10):825-32.

3. Bailey FA. “Introduction to Palliative Care.” The Palliative Response. Menasha Ridge Press. 2003; pp. 3-6.

Advance Care Plannin

1. Prendergast T. Advance care planning: pitfalls, progress, promise. Crit Care Med. 2001; 29(2):Supplement N34-9.

2. Schwartz C. Honing an advance care planning intervention using qualitative analysis: the living well interview” J Palliat Med. 2003;6:593-603.

3. Bailey FA. “Advanced Care Planning.” The Palliative Response. Menasha Ridge Press, 2005. Section 5.3

Anorexia & Artificial Hydration/Nutrition
1. Finucane TE, et al. Tube feeding in patients with advanced dementia. JAMA. 1999; 282(14):1365-70.

2. Casarett D, et al. Appropriate use of artificial nutrition and hydration – fundamental principles and recommendations. N Engl J Med. 2005; 353(24):2607-12.

3. Yavuzsen T, et al. Systematic review of the treatment of cancer-associated anorexia and weight loss. J Clin Oncol. 2005; 23(33):8500-11.

1. Minton O, et al. Drug therapy for the management of cancer related fatigue. Cochrane Database of Systematic Reviews. 2010; July 7.

2. Kerr CW, et al. Effects of methylphenidate on fatigue and depression: A double blind randomized controlled trial. J Pain Symptom Manage. 2012; 43(1):68-77.

3. Bailey FA. “Fatigue.” The Palliative Response. Menasha Ridge Press, 2005. Section 1.2


1. Back AL, Arnold RM, & Quill TE. Hope for the best, and prepare for the worst. Ann Intern Med. 2003; 138(5):439-43.

2. Baile WF, et al. SPIKES—A six-step protocol for delivering bad news: Application to the patient with cancer. Oncologist. 2000; 5:302-11.

3. Lo B, et al. Discussing palliative care with patients. Ann Intern Med. 1999; 130:744-9.

4. Quill TE, Arnold RM, & Platt F. “I wish things were different”: Expressing wishes in response to loss, futility, and unrealistic hopes. Ann Intern Med. 2001; 135(7):551-5.

1. Young J, Inouye SK. Delirium in elderly people. Lancet. 2014; 383: 911-22.

2. Moyer, D. Review article: Terminal delirium in geriatric patients with cancer at the end of life. Am J Hospice Palliat Care. 2011; 28(1):44-51.

3. Bailey, FA. “Delirium.” The Palliative Response. Menasha Ridge Press, 2005. Section 3.1. 

1. Bailey FA. “Depression.” The Palliative Response. Menasha Ridge Press, 2005. Section 3.3. 

2. Pereira J & Bruera E. Depression with psychomotor retardation: Diagnostic challenges and the use of psychostimulants. J Palliat Med. 2001; 4(1):15-2.

3. Taylor L, et al. Diagnosis of depression in patients receiving specialist community palliative care: Does using a single screening question identify depression otherwise diagnosed by clinical interview? J Palliat Med. 2013; 16(9):1140-2.

1. Mahler DA, et al. American College of Chest Physicians consensus statement on the management of dyspnea in patients with advanced lung or heart disease. Chest. 2010; 137(3): 674-91.

2. Abernathy AP, et al. Effect of palliative oxygen versus room air in relief of breathlessness in patients with refractory dyspnea: a double-blind, randomized controlled trial. Lancet. 2010; 376: 784-93.

3. Jennings, AL, et al. Opioids for the palliation of breathlessness in advanced disease and terminal illness. Cochrane Database of Scientific Reviews. 2001(3).

4. Wildiers, H, & Menten, J. Death rattle: prevalence, prevention and treatment. J Pain Symptom Manage. 2002; 23(4):310-7.

5. Bailey FA. “Physical Suffering: Dyspnea.” The Palliative Response. 2nd edition. Menasha Ridge Press, 2005: 27-31.

1. Quill TE, Lee BC, Nunn S. Palliative treatments of last resort: Choosing the least harmful alternative. Ann Intern Med. 2000,132:488-93.

2. Bloche, MG. The Supreme Court and the purposes of medicine. N Engl J Med. 2006, 254;10.

GI Symptoms
1. Bailey FA. Physical Suffering: Constipation, Nausea and Vomiting. The Palliative Response. 2nd edition. USA: Menasha Ridge Press, 2005. 21-25, 39-43.

2. Portenoy RK, et al. Subcutaneous methylnaltrexone for the treatment of opioid-induced constipation in patients with advanced illness: a double-blind, randomized, parallel group, dose-ranging study. J Pain Symptom Manage. 2008; 35 (5): 458-468.

3. Ripamonti CI, Easson AM, & Gerdes H. Management of malignant bowel obstruction. Eur J Cancer. 2008; 44 (8): 1105-1115.

1. Kochhar R, et al. Opioids in cancer pain: common dosing errors. Oncology. 2003; 17:571-9.

2. Mercadante S, Caraceni A. Conversion ratios for opioid switching in the treatment of cancer pain: a systematic review. Palliat Med. 2011; 25(5):504-15.

3. Balducci L. Management of cancer pain in geriatric patients. J Support Oncol. 2003; 1(3):175-91.

4. Foley KM. Opioids and chronic neuropathic pain. N Engl J Med. 2003; 348:1279-81.

1. Bailey FA. “Medicare Hospice Benefit,” The Palliative Response. Menasha Ridge Press, 2005. Section 2.2

2. Christakis NA & Lamont EB Extent and determinants of error in doctors' prognoses in terminally ill patients: prospective cohort study. BMJ. 2000; 320:469-73.

3. Head B, Ritchie CS, & Smoot TM. Prognostication in hospice care: can the palliative performance scale help? J Palliat Med. 2005; 8(3):492-502.

4. Moss AH, et al. Prognostic significance of the "surprise" question in cancer patients. J Palliat Med. 2010;13(7):837-40.

1. Fosarelli, P. Medicine, spirituality, and patient care. JAMA. 2008; 300(7):836-8.

2. Lo, B, et al. Discussing religious and spiritual issues at the end of life: A practical guide for physicians. JAMA. 2002; 287(6):749-54.

3. Puchalski, CM. Spirituality and end-of-life care: A time for listening and caring. J Palliat Med. 2002; 5(2):289-94.

4. Chochinov HM, et al. The effect of dignity therapy on distress and end-of-life experience in terminally ill patients: a randomised controlled trial. Lancet Oncol. 2011; 12(8):753-62.